IDEX (NYSE:IEX) Issues FY 2026 Earnings Guidance

by · The Cerbat Gem

IDEX (NYSE:IEXGet Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 8.150-8.35 for the period, compared to the consensus estimate of 8.310. The company issued revenue guidance of -, compared to the consensus revenue estimate of $3.5 billion. IDEX also updated its Q1 2026 guidance to 1.730-1.780 EPS.

IDEX Stock Performance

NYSE IEX traded up $6.95 on Wednesday, reaching $208.56. 987,242 shares of the stock were exchanged, compared to its average volume of 760,148. IDEX has a one year low of $153.36 and a one year high of $210.90. The firm has a market capitalization of $15.61 billion, a PE ratio of 33.00, a PEG ratio of 1.99 and a beta of 1.00. The company’s 50-day simple moving average is $184.24 and its two-hundred day simple moving average is $172.50. The company has a current ratio of 2.93, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47.

IDEX (NYSE:IEXGet Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The industrial products company reported $2.10 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.06. The business had revenue of $899.10 million during the quarter, compared to analyst estimates of $882.00 million. IDEX had a net margin of 13.97% and a return on equity of 15.20%. The company’s revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the business posted $2.04 earnings per share. IDEX has set its Q1 2026 guidance at 1.730-1.780 EPS and its FY 2026 guidance at 8.150-8.35 EPS. Analysts expect that IDEX will post 8.26 EPS for the current fiscal year.

IDEX Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, January 16th were given a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 1.4%. The ex-dividend date was Friday, January 16th. IDEX’s payout ratio is presently 44.94%.

Wall Street Analyst Weigh In

IEX has been the subject of several research analyst reports. Stifel Nicolaus increased their target price on IDEX from $200.00 to $220.00 and gave the stock a “buy” rating in a research report on Friday, January 23rd. Oppenheimer set a $210.00 price target on IDEX in a research note on Tuesday, October 7th. Royal Bank Of Canada reiterated an “outperform” rating and set a $211.00 price objective on shares of IDEX in a research report on Thursday, January 15th. Citigroup boosted their target price on shares of IDEX from $197.00 to $202.00 and gave the stock a “buy” rating in a report on Monday, December 8th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of IDEX in a research note on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $203.29.

Read Our Latest Analysis on IEX

IDEX News Roundup

Here are the key news stories impacting IDEX this week:

  • Positive Sentiment: IDEX beat top‑line and bottom‑line estimates for Q4 — reported EPS of $2.10 (vs. ~ $2.04 consensus) and revenue of $899.1M (vs. ~$882M). The quarter showed 4.2% revenue growth year‑over‑year and maintained solid margins and ROE, giving evidence of operational resilience. View Press Release
  • Positive Sentiment: Multiple outlets highlight the beats and key metrics that underpin the stock’s strength today — analysts and news services emphasized both the EPS and revenue outperformance. Idex (IEX) Q4 Earnings and Revenues Beat Estimates
  • Neutral Sentiment: The company provided Q1 and FY‑2026 guidance (Q1: $1.730–1.780; FY: $8.150–8.350). Management’s transparency on the outlook removes uncertainty, but the ranges leave room for interpretation. IDEX beats top-line and bottom-line estimates; initiates Q1 and FY26 outlook
  • Negative Sentiment: Q1 guidance was below consensus (company: $1.730–1.780 vs. consensus ~ $1.84), which could pressure near‑term estimates and raise revision risk for Q1. Investors may reassess short‑term momentum despite the quarter’s beat. Listen to Conference Call
  • Negative Sentiment: FY‑2026 guidance slightly undercuts the Street midpoint (guidance low end below some estimates), introducing modest downside risk to consensus FY numbers even though the range overlaps analyst expectations. Compared to Estimates, Idex (IEX) Q4 Earnings

Institutional Investors Weigh In On IDEX

Large investors have recently added to or reduced their stakes in the stock. Jain Global LLC purchased a new position in shares of IDEX in the 3rd quarter worth approximately $1,265,000. Franklin Resources Inc. lifted its position in IDEX by 5.0% in the third quarter. Franklin Resources Inc. now owns 8,120 shares of the industrial products company’s stock worth $1,322,000 after buying an additional 389 shares during the last quarter. Creative Planning lifted its position in IDEX by 11.9% in the third quarter. Creative Planning now owns 13,569 shares of the industrial products company’s stock worth $2,208,000 after buying an additional 1,444 shares during the last quarter. Bank of Nova Scotia boosted its stake in IDEX by 24.7% during the third quarter. Bank of Nova Scotia now owns 9,277 shares of the industrial products company’s stock worth $1,510,000 after buying an additional 1,835 shares during the period. Finally, Ossiam increased its position in IDEX by 27.9% during the third quarter. Ossiam now owns 4,847 shares of the industrial products company’s stock valued at $789,000 after acquiring an additional 1,056 shares during the last quarter. 97.96% of the stock is owned by institutional investors.

About IDEX

(Get Free Report)

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.

Featured Articles